Results 91 to 100 of about 47,297 (213)

Pathological assessment of tumour beds in breast excisions post‐neoadjuvant therapy: a retrospective cohort study

Histopathology, EarlyView.
Pathological assessment of post‐neoadjuvant treatment (NAT) breast specimens uses more laboratory resources compared with non‐NAT cases. The highest resource utilization (specimen resampling, number of tissue blocks submitted, pathologist review) occurred when the tumour bed is not grossly identifiable.
Angela Cheng, Penelope Barnes, Daniel Rayson, Christopher Liwski, Gillian Bethune   +4 more
wiley   +1 more source

Zebrafish as a practical and convenient model for the study of photodynamic and photothermal therapy of solid tumors: A scoping review

Photochemistry and Photobiology, EarlyView.
Zebrafish provide a high‐throughput, optically transparent platform for cancer and drug screening. Their ~80% genetic homology, xenograft compatibility, and transgenic strains enable targeted photosensitizer screening, real‐time ROS and tumor imaging, and mechanistic assays, while fish embryo acute toxicity (FET) and in vitro tests streamline toxicity ...
Ethan Wilson, Alexander Fiorentino, Brian W. Booth, Valery Bliznyuk, Diana Ivankovic, Luigi Boccuto   +5 more
wiley   +1 more source

Transcriptomic Profiling of Canine Mammary Tumours Reveals Significant Heterogeneity Between and Within Histological Classes

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT This study presents a comprehensive transcriptomic analysis of 128 canine mammary tumours (CMTs), aiming to characterize their molecular landscape. Differential gene expression analysis (DGE), gene set enrichment analysis (GSEA) and clustering based on the human PAM50 gene panel were applied to explore molecular differences between the ...
Ingrid Marie Moberg, Nina Hansen, Helga Bergholtz, Kaja Sverdrup Borge, Gjermund Gunnes, Ellen Frøysadal Arnet, Ole Albert Guttersrud, Monica Hongrø Solbakken, Frode Lingaas   +8 more
wiley   +1 more source

Evaluation of Additional Treatment for Residual Cases After Endoscopic Papillectomy of Duodenal Ampullary Tumors

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Background and Aims This study aimed to assess the prognosis and outcomes of additional treatment for residual adenocarcinoma and adenoma following endoscopic papillectomy (EP) for ampullary tumors. Methods Of 191 patients who underwent EP, 43 with adenocarcinoma or adenoma and either positive or unknown pathological margins were included ...
Yusuke Kurita, Keiki Nagai, Noriki Kasuga, Kensuke Kubota, Yuji Fujita, Yusuke Sekino, Hiroki Uechi, Yuji Koyama, Shintaro Tsujikawa, Shota Matsumoto, Shigeki Tamura, Yu Honda, Shin Yagi, Takeshi Iizuka, Sho Hasegawa, Takamitsu Sato, Kunihiro Hosono, Noritoshi Kobayashi, Yuki Honma, Ryusei Matsuyama, Jotaro Harada, Masato Yoneda, Satoshi Fujii, Itaru Endo, Atsushi Nakajima   +24 more
wiley   +1 more source

An Update on Early‐Onset Breast Cancer: Incidence, Risk Factors, Genetic Testing, and Treatment

Computational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT Early‐onset breast cancer presents in patients typically under the age of 40, while very early‐onset breast cancer is usually viewed as breast cancer occurring before the age of 35. Early‐onset breast cancer demonstrates specific molecular properties and has worse outcomes compared to its late‐onset breast cancer counterpart.
Leila Jahangiri
wiley   +1 more source

The Predictive Value of the Tumor‐Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor‐Positive Breast Cancer

International Journal of Cancer, Volume 159, Issue 4, Page 1056-1067, 15 August 2026.
Neoadjuvant endocrine therapy (NET) can help prevent metastases and improve survival in patients with hormone receptor‐positive (HR+) breast cancer. Identifying which HR+ patients will benefit from NET, however, remains challenging. Here, in a patient cohort in the Netherlands, the authors evaluated tumor‐stroma ratio (TSR) and magnetic resonance ...
Layla Andour, Sophie C. Hagenaars, Anne Florine de Groot, Elly M. M. Krol‐Warmerdam, Judith R. Kroep, Hans Marten Hazelbag, Gerrit‐Jan Liefers, Marieke E. Straver, Wilma E. Mesker   +8 more
wiley   +1 more source

Cervical Metastasis From Primary Breast Carcinoma: A Case Report and Review of Extragenital Tumors Involving the Uterine Cervix

Clinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Cervical metastases from breast carcinoma should be considered in the differential diagnosis of uterine lesions in patients with prior breast cancer. Re‐biopsy is essential to detect receptor discordance (ER/PR up to 29%) and guide therapy. GCDFP‐15, mammaglobin, and GATA3 confirm mammary origin.
Mario Assenza, Adele Zappalà, Armando Nallbani, Jacopo Wabersich   +3 more
wiley   +1 more source

Molecular profiling of breast cancer pleural effusions using cytology specimens: Impact of sample source and cytological features on next‐generation sequencing performance

Cancer Cytopathology, Volume 134, Issue 7, July 2026.
ABSTRACT Background Malignant effusions in breast cancer are a minimally invasive source for molecular profiling. Effusion‐derived cytology specimens, cell blocks (CB) and post‐ThinPrep PreservCyt (PTPC) supernatant, are reliable sources for molecular testing but differ in DNA concentration and turnaround time (TAT).
Harpreet Virk, Claire Michael, Keri Ann Pfeil, Navid Sadri, Philip Bomeisl, Aparna Harbhajanka   +5 more
wiley   +1 more source

Expert Discussion: Ductal Carcinoma in situ [PDF]

Breast Care, 2021
Peter Dall, Jörg Heil, Maggie Banys-Paluchowski, David Krug, Wilfried Budach, Cornelia Kolberg-Liedtke, Toralf Reimer   +6 more
openaire   +2 more sources